84243-56-1

Basic information

• Product Name: 4-(1H-imidazol-1-yl)-β-oxobenzenepropanoic acid methyl ester
• Synonyms: 4-(1H-imidazol-1-yl)-β-oxobenzenepropanoic acid methyl ester
• CAS NO: 84243-56-1
• Molecular Weight: 244.25
• Mol File: 84243-56-1.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 4-(1H-imidazol-1-yl)-β-oxobenzenepropanoic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(1H-imidazol-1-yl)-β-oxobenzenepropanoic acid methyl ester(84243-56-1)
• EPA Substance Registry System: 4-(1H-imidazol-1-yl)-β-oxobenzenepropanoic acid methyl ester(84243-56-1)

Safety Data

• Hazardous Substances Data: 84243-56-1(Hazardous Substances Data)

Upstream product

• 10041-06-2 4'-(imidazol-1-yl)acetophenone 
• 616-38-6 carbonic acid dimethyl ester 

Downstream Products

• 108818-74-2 2,4-dihydro-5-[4-(1H-imidazol-1-yl)phenyl]-3H-pyrazol-3-one 
• 108818-65-1 α-ethyl-4-(1H-imidazol-1-yl)-α-methyl-β-oxobenzenepropanoic acid methyl ester 
• 84243-57-2 4-(1H-imidazol-1-yl)-γ-oxobenzenebutanoic acid 
• 108818-85-5 4,4-Dibenzyl-5-(4-imidazol-1-yl-phenyl)-2,4-dihydro-pyrazol-3-one 
• 108818-77-5 4-Hexyl-5-(4-imidazol-1-yl-phenyl)-2,4-dihydro-pyrazol-3-one 
• 108818-66-2 2-Benzyl-3-(4-imidazol-1-yl-phenyl)-2-methyl-3-oxo-propionic acid methyl ester 
• 108818-80-0 4-Benzyl-5-(4-imidazol-1-yl-phenyl)-4-methyl-2,4-dihydro-pyrazol-3-one 
• 108818-78-6 4-Benzyl-5-(4-imidazol-1-yl-phenyl)-2,4-dihydro-pyrazol-3-one 
• 108818-86-6 4-(4-Imidazol-1-yl-phenyl)-2,3-diaza-spiro[4.5]dec-3-en-1-one 
• 108818-82-2 4-(4-Imidazol-1-yl-phenyl)-2,3-diaza-spiro[4.4]non-3-en-1-one 
• 108818-81-1 4,4-Diethyl-5-(4-imidazol-1-yl-phenyl)-2,4-dihydro-pyrazol-3-one 
• 95644-25-0 4-ethyl-2,4-dihydro-5-[4-(1H-imidazol-1-yl)phenyl]-4-methyl-3H-pyrazol-3-one 
• 108818-76-4 4-Ethyl-5-(4-imidazol-1-yl-phenyl)-2,4-dihydro-pyrazol-3-one 
• 108818-75-3 5-(4-Imidazol-1-yl-phenyl)-4-methyl-2,4-dihydro-pyrazol-3-one 

Relevant articles and documents

1,4-DIHYDROPYRIDINE DERIVATIVES

A 1,4-dihydropyridine derivative having the formula (I): wherein, R1represents a substituted or unsubstituted phenyl or heterocyclic group, R2represents a C1to C5lower alkyl group, R3represents a substituted or unsubstituted C2to C8alkyl, alkenyl, alkynyl or substituted or unsubstituted cycloalkyl group, R4represents -A-R5, wherein A represents a C2to C8alkylene group or a substituted or unsubstituted C2to C8alkenylene group, and R5represents a substituted or unsubstituted pyridyl, pyridylcarbonyl or piperadinyl group and a drug for overcoming resistance to an anti-cancer drug or a drug increasing the effect of an anti-cancer drug containing as an effective ingredient the derivative or its pharmacologically acceptable salt or hydrate.

Cardiotonic Agents. 2. Synthesis and Structure-Activity Relationships of 4,5-Dihydro-6--3(2H)-pyridazinones: A New Class of Positive Inotropic Agents

A series of 4,5-dihydro-6--3(2H)-pyridazinones and related compounds were synthesized and evaluated for positive inotropic activity.Most members of this series produced dose-related increases in myocardial contractility that we